TAP1 and neoplasm: The level of TAP1 could affect the survival time of patients with oral squamous cell carcinoma (SCCOT) and breast cancer, and may serve as a tumor marker for the early diagnosis and follow-up of SCCOT (Henle et al., 2017; Attaran et al., 2020).